Clinical Trial Spotlight: Pemetrexed (ALIMTA) Plus Cisplatin for Mesothelioma MesotheliomaHelp.net The goal enrollment for the trial is 45 patients that have been diagnosed with malignant pleural mesothelioma but have not yet undergone treatment.


Read the whole story here:
Clinical Trial Spotlight: Pemetrexed (ALIMTA) Plus Cisplatin for Mesothelioma – MesotheliomaHelp.net